Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)
ClinicalTrials.gov study NCT04762498. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components
ClinicalTrials.gov study NCT02305732. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
ClinicalTrials.gov study NCT04095793. IPD Sharing: NO. Countries: 18. Publications: 0.
An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT05798117. IPD Sharing: YES. Countries: 5. Publications: 0.
An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
ClinicalTrials.gov study NCT05900141. IPD Sharing: YES. Countries: 1. Publications: 0.
Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study
ClinicalTrials.gov study NCT02100644. IPD Sharing: YES. Countries: 1. Publications: 0.
An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)
ClinicalTrials.gov study NCT03675126. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01563055. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
ClinicalTrials.gov study NCT02871297. IPD Sharing: Not stated. Countries: 20. Publications: 0.
Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
ClinicalTrials.gov study NCT05188729. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
ClinicalTrials.gov study NCT01136967. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C
ClinicalTrials.gov study NCT02493036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.
ClinicalTrials.gov study NCT02316847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
ClinicalTrials.gov study NCT00241176. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain
ClinicalTrials.gov study NCT00976716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
ClinicalTrials.gov study NCT02342548. IPD Sharing: Not stated. Countries: 5. Publications: 0.
W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Perox
ClinicalTrials.gov study NCT01132443. IPD Sharing: YES. Countries: 0. Publications: 1.
Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
ClinicalTrials.gov study NCT00038103. IPD Sharing: Not stated. Countries: 9. Publications: 0.
An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies
ClinicalTrials.gov study NCT03842969. IPD Sharing: YES. Countries: 8. Publications: 0.
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
ClinicalTrials.gov study NCT00765999. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.